Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC3981373

Medchemexpress LLC MedChemExpress ITK PROTAC Degrader, ITK Target, 1022.20 MW, 98.31% Purity
SDP

Catalog No. NC3981373
Encompass

BSJ-05-037 is an ITK PROTAC degrader that effectively targets and degrades ITK in T-cell lymphoma cell lines. It blocks the activation of the NF-κB/GATA-3 signaling pathway, inhibits PLCγ1 phosphorylation, and reduces the proliferative capacity of T-cell lymphoma cells. This compound enhances the sensitivity of T-cell lymphoma cells to chemotherapy and is applicable to research related to T-cell lymphoma.

  • Targets and degrades ITK in T-cell lymphoma cell lines.
  • Blocks the activation of the NF-κB/GATA-3 signaling pathway.
  • Inhibits PLCγ1 phosphorylation.
  • Reduces the proliferative capacity of T-cell lymphoma cells.
  • Enhances the sensitivity of T-cell lymphoma cells to chemotherapy.
  • Decreases tumor volume in mouse models.
  • Reverses chemotherapy resistance in mouse models.

Catalog No. NC3981373 Supplier Medchemexpress LLC Supplier No. HY18520610MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

BSJ-05-037 is an ITK PROTAC degrader that effectively targets and degrades ITK in T-cell lymphoma cell lines. It blocks the activation of the NF-κB/GATA-3 signaling pathway, inhibits PLCγ1 phosphorylation, and reduces the proliferative capacity of T-cell lymphoma cells. This compound enhances the sensitivity of T-cell lymphoma cells to chemotherapy and is applicable to research related to T-cell lymphoma.

  • Targets and degrades ITK in T-cell lymphoma cell lines.
  • Blocks the activation of the NF-κB/GATA-3 signaling pathway.
  • Inhibits PLCγ1 phosphorylation.
  • Reduces the proliferative capacity of T-cell lymphoma cells.
  • Enhances the sensitivity of T-cell lymphoma cells to chemotherapy.
  • Decreases tumor volume in mouse models.
  • Reverses chemotherapy resistance in mouse models.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.